Abstract
Six months' cyclophosphamide treatment significantly increased the sulfhydryl (SH) serum levels in all 12 rheumatoid arthritis (RA) patients studied and significantly decreased the PIP joints' technetium index (Tc-index), the erythrocyte sedimentation rate (ESR), and the joint count.